Publications by authors named "Manish Monga"

Claim this Profile
E
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
Arlene O Siefker-Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert A Huddart, Manish Monga

Lancet Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Maura L Gillison, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Manish Monga

Oncologist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.
Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, Tomoya Yokota, Chia-Jui Yen, Manish Monga

Oral Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
Alexander Chi, Sijin Wen, Manish Monga, Mohammed Almubarak, Xiaoqing He

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Kevin J Harrington, Robert L Ferris, George Blumenschein, A Dimitrios Colevas, Jérôme Fayette, Manish Monga

Lancet Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
Robert L Ferris, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Manish Monga

N Engl J Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).
Chandra P Belani, Suzanne E Dahlberg, Charles M Rudin, Martin Fleisher, Helen X Chen, Manish Monga

Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.
Todd Hembrough, Wei-Li Liao, Christopher P Hartley, Patrick C Ma, Vamsidhar Velcheti, Manish Monga

Clin Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms.
William D Figg, Manish Monga, Donna Headlee, Avni Shah, Cindy H Chau

Cancer Chemother Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib and thyroid cancer.
Chandler Park, Jessica Perini, Roger W Farmer, Tanya Fancy, Manish Monga

Expert Rev Endocrinol Metab· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: image guidance and beyond.
Alexander Chi, Nam Phong Nguyen, James S Welsh, William Tse, Manish Monga

Front Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.
Soumit K Basu, Scot C Remick, Manish Monga, Laura F Gibson

Clin Exp Metastasis· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatment for melanoma.
Manish Monga, Jame Abraham

Expert Rev Anticancer Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a statewide clinical trials network for cancer care in West Virginia.
Jame Abraham, James Keresztury, John Azar, Manish Monga, Timothy Bowers

W V Med J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma.
Qin C Ryan, Donna Headlee, Milin Acharya, Alex Sparreboom, Jane B Trepel, Manish Monga

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal transduction--directed cancer treatments.
Edward A Sausville, Yusri Elsayed, Manish Monga, George Kim

Annu Rev Pharmacol Toxicol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis